Department of Neuropathology, Medical Research Institute, Center for Brain Integration Research, Tokyo Medical and Dental University, Japan.
Neurochem Int. 2018 Oct;119:17-25. doi: 10.1016/j.neuint.2017.06.005. Epub 2017 Jun 13.
PQBP1 (polyglutamine binding protein-1) is the earliest identified molecule among the group of disease-related intrinsically disordered/denatured proteins. PQBP1 interacts with splicing-related factors via the disordered/denatured domain and regulates post-transcriptional gene expression. The mutations cause intellectual disability due to decreased dendritic spines and abnormal expression of synapse molecules in neurons, and microcephaly due to elongated cell cycle time and abnormal expression of cell cycle proteins in neural stem progenitor cells. Meanwhile, PQBP1 interacts with polyglutamine tract sequences translated from CAG triplet disease genes via their disordered/denatured structures. The second hit on PQBP1 by such neurodegenerative disease proteins is supposed to similarly impair synapse functions in neuron and proliferation of stem cells. The alteration of gene expression profile and consequently induced phenotypes of neuron and stem cells via secondary impairment of the intrinsically disordered/denatured protein PQBP1, which are similar to developmental disorders by PQBP1 gene mutations, could be a part of the main pathologies shared by multiple neurodegenerative diseases.
PQBP1(多聚谷氨酰胺结合蛋白 1)是疾病相关无规则/变性蛋白组中最早被识别的分子。PQBP1 通过无规则/变性结构域与剪接相关因子相互作用,调节转录后基因表达。突变导致智力障碍,原因是树突棘减少和神经元中突触分子表达异常,微脑畸形是由于神经干细胞祖细胞的细胞周期时间延长和细胞周期蛋白表达异常。同时,PQBP1 通过其无规则/变性结构与从 CAG 三核苷酸疾病基因翻译的多聚谷氨酰胺序列相互作用。假定神经退行性疾病蛋白对 PQBP1 的第二次打击同样会损害神经元中的突触功能和干细胞的增殖。通过对内在无序/变性蛋白 PQBP1 的二次损伤,改变基因表达谱并由此诱导神经元和干细胞的表型,类似于 PQBP1 基因突变引起的发育障碍,可能是多种神经退行性疾病共同的主要病理的一部分。